Accuray Incorporated will be showcasing the benefits of its radiotherapy systems and software solutions at the 37th annual European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain. The April 20-24 meeting will attract more than 3,000 radiation oncology professionals who will gather to gain information and insights on the latest developments in radiation therapy. Accuray will be in attendance at booth #1700, sharing information on new treatment approaches and providing opportunities for conversations about how the company's CyberKnife and Radixact Systems, and advanced software solutions, can help improve the radiation therapy treatment experience for clinicians and their patients.
"This year, Accuray has chosen a theme which is anchored in our company culture and conveys our new corporate positioning: 'Innovating Patient-First Cancer Treatment.' This is not just a tagline. It is who we are, what we do and what makes us different. As the fight against cancer grows more complex, we will continually introduce new thinking and fresh tools to drive patient outcomes to entirely new levels," said Lionel Hadjadjeba, M.D., Senior Vice President, and Chief Commercial Officer at Accuray.
Special Events: Accuray Booth #1700
As described in a company release, Accuray is building on its history of innovation with a new approach for demonstrating product features and benefits, and a new award recognizing customer advances achieved with its products.
April 21, 2018 at 9:30 a.m.: Unveiling of hologram technology, "viRTual - Where Art Meets Science"
April 21, 2018 at 2:10 p.m.: Announcement of first annual ESTRO Accuray Innovation Awards
Accuray ESTRO37 Highlights: Advances in Software Solutions
Radiation Oncology Experts Share First-Hand Experience with Accuray Technologies
ESTRO attendees are invited to take part in multiple educational opportunities. Over the course of the meeting, a symposium and numerous Accuray Exchange in Radiation Oncology (AERO™) sessions will provide information on a range of subjects designed to advance clinical practice and enhance patient outcomes.
Accuray showcasing patient-first cancer treatments at ESTRO 37. Appl Rad Oncol.